133 related articles for article (PubMed ID: 25784779)
1. Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease.
Chao CT; Chen YC; Chiang CK; Huang JW; Hu FC; Fang CC; Chang CC; Yen CJ
Dis Markers; 2015; 2015():763459. PubMed ID: 25784779
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
[TBL] [Abstract][Full Text] [Related]
3. Interplay between Superoxide Dismutase, Glutathione Peroxidase, and Peroxisome Proliferator Activated Receptor Gamma Polymorphisms on the Risk of End-Stage Renal Disease among Han Chinese Patients.
Chao CT; Chen YC; Chiang CK; Huang JW; Fang CC; Chang CC; Yen CJ
Oxid Med Cell Longev; 2016; 2016():8516748. PubMed ID: 26881045
[TBL] [Abstract][Full Text] [Related]
4. Diabetes mellitus, superoxide dismutase and peroxisome proliferator activated receptor gamma polymorphisms modify the outcome of end-stage renal disease patients of Han Chinese origin.
Chao CT; Huang JW; Chiang CK; Chen YC; Fang CC; Hu FC; Chang CC; Yen CJ
Nephrology (Carlton); 2018 Feb; 23(2):117-125. PubMed ID: 27925431
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma gene polymorphism and risk of cardiovascular disease in patients with diabetic nephropathy.
Szeto CC; Chow KM; Poon PY; Kwan BC; Li PK
Am J Nephrol; 2008; 28(5):715-22. PubMed ID: 18417957
[TBL] [Abstract][Full Text] [Related]
6. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
[TBL] [Abstract][Full Text] [Related]
7. PPAR-gamma gene polymorphisms and psoriatic arthritis.
Butt C; Gladman D; Rahman P
J Rheumatol; 2006 Aug; 33(8):1631-3. PubMed ID: 16783862
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the peroxisome proliferator-activated receptor-γ (rs1801282) and its coactivator-1 (rs8192673) are associated with obesity indexes in subjects with type 2 diabetes mellitus.
Kruzliak P; Haley AP; Starcevic JN; Gaspar L; Petrovic D
Cardiovasc Diabetol; 2015 Apr; 14():42. PubMed ID: 25928419
[TBL] [Abstract][Full Text] [Related]
9. Distribution of peroxisome proliferator-activated receptor-gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel disease.
Shrestha UK; Karimi O; Crusius JB; Zhou F; Wang Z; Chen Z; van Bodegraven AA; Xiao J; Morré SA; Wang H; Li J; Xia B
Inflamm Bowel Dis; 2010 Feb; 16(2):312-9. PubMed ID: 19714744
[TBL] [Abstract][Full Text] [Related]
10. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case-Control Study.
Unal E; Aslan EI; Ozturk T; Kurnaz Gomleksiz O; Kucukhuseyin O; Tuzuner MB; Seyhan MF; Ozturk O; Yilmaz Aydogan H
Biochem Genet; 2021 Dec; 59(6):1413-1426. PubMed ID: 33893920
[TBL] [Abstract][Full Text] [Related]
12. Association between PPAR-γ and RXR-α gene polymorphism and metabolic syndrome risk: a case-control study of a Chinese Han population.
Shi H; Yu X; Li Q; Ye X; Gao Y; Ma J; Cheng J; Lu Y; Du W; Du J; Ye Q; Zhao X; Zhou L
Arch Med Res; 2012 Apr; 43(3):233-42. PubMed ID: 22475777
[TBL] [Abstract][Full Text] [Related]
13. Association of peroxisome proliferator-activated receptorγ gene Pro12Ala and C161T polymorphisms with cardiovascular risk factors in maintenance hemodialysis patients.
Liu F; Mei X; Zhang Y; Qi H; Wang J; Wang Y; Jiang W; Zhang X; Yan H; Zhuang S
Mol Biol Rep; 2014 Nov; 41(11):7555-65. PubMed ID: 25096510
[TBL] [Abstract][Full Text] [Related]
14. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
[TBL] [Abstract][Full Text] [Related]
15. Impact of nitric oxide synthase Glu298Asp polymorphism on the development of end-stage renal disease in type 2 diabetic Egyptian patients.
El-Din Bessa SS; Hamdy SM
Ren Fail; 2011; 33(9):878-84. PubMed ID: 21854353
[TBL] [Abstract][Full Text] [Related]
16. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
Zhang H; Zhu S; Chen J; Tang Y; Hu H; Mohan V; Venkatesan R; Wang J; Chen H
Diabetes Care; 2012 Jun; 35(6):1388-93. PubMed ID: 22619290
[TBL] [Abstract][Full Text] [Related]
19. Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma on colorectal cancer in an Indian population.
Jiang J; Gajalakshmi V; Wang J; Kuriki K; Suzuki S; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
Cancer Sci; 2005 Aug; 96(8):507-12. PubMed ID: 16108832
[TBL] [Abstract][Full Text] [Related]
20. Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPARgamma) gene in inflammatory bowel disease.
Atug O; Tahan V; Eren F; Tiftikci A; Imeryuz N; Hamzaoglu HO; Tozun N
J Gastrointestin Liver Dis; 2008 Dec; 17(4):433-7. PubMed ID: 19104705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
